Aurobindo Pharma Limited (BOM:524804)

Market Cap	605.25B
Revenue (ttm)	320.25B
Net Income (ttm)	33.91B
Shares Out	n/a
EPS (ttm)	58.32
PE Ratio	17.85
Forward PE	15.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,770
Average Volume	33,062
Open	1,073.25
Previous Close	1,065.35
Day's Range	1,040.00 - 1,073.25
52-Week Range	994.35 - 1,592.55
Beta	n/a
RSI	31.04
Earnings Date	Aug 14, 2025

About Aurobindo Pharma

Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibi...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Employees: 26,015
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524804

Financial Performance

In 2024, Aurobindo Pharma's revenue was 317.24 billion, an increase of 9.39% compared to the previous year's 290.02 billion. Earnings were 34.86 billion, an increase of 9.86%.